Fundz

Adipo Therapeutics completes $1.9M seed funding bridge to advance obesity and Type 2 diabetes treatment

PRIVATEJan 31, 2024

Amount Raised

$1.9 Million

Round Type

Seed

IndianapolisBiotechnologyHealth CareTherapeuticsBiopharma

Investors

Vision Tech PartnersIU VenturesElevate VenturesPurdue Research Foundation

Description

Adipo Therapeutics has successfully completed a $1.9 million seed funding bridge to advance obesity and Type 2 diabetes treatment. The company will embark on raising $35M Series A financing.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as Adipo Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Crinetics Pharmaceuticals raised $350M on March 1, 2024.
  • Parabilis Medicines raised $145M (Series E) on March 1, 2024.
  • Denali Therapeutics raised $500M on February 29, 2024.
  • vTv Therapeutics Inc. raised $51M on February 27, 2024.
  • IsomAb raised $7.5M (Seed) on February 20, 2024.
  • HCW Biologics raised $2.5M (Seed) on February 20, 2024.

Who to call at Adipo Therapeutics, and when

A new round usually means Adipo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Adipo Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Adipo Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Adipo Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Adipo Therapeutics

Location

1210 Waterway Blvd.

Indianapolis, Indiana, United States

About

Adipo Therapeutics, an Indiana biotechnology company, is developing polymer-based, Notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue to induce browning, or white-to-beige adipocyte transformation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Adipo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMeng D., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Adipo Therapeutics's next move

See what Strategic adds

Adipo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.